𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

✍ Scribed by M. C. Alonso; J. M. Tabernero; B. Ojeda; M. Llanos; C. Solà; M. A. Climent; M. A. Seguí; J. J. López

Publisher
Springer US
Year
1995
Tongue
English
Weight
788 KB
Volume
34
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized multicenter trial of cyclop
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
✍ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-

The eastern cooperative oncology group e
The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer
✍ Geoffrey Falkson; Rebecca S. Gelman; Douglass C. Tormey; Frank J. Cummings; Paul 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 3 views

Data on 162 women (90 premenopausal and 72 postmenopausal) with metastatic breast cancer randomized to receive cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF) on two Eastern Cooperative Oncology Group (ECOG) protocols were analyzed. Twenty-three percent had complete remission; 39

Combination chemoimmunotherapy of metast
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG
✍ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

One hundred five patients with metastatic breast cancer were treated with 5-fluorouracil, Adriamycin, cyclophosphamide and BCG (FAC-BCG). The results were compared to those observed in a group of 44 patients treated with FAC chemotherapy alone. Although the overall response rates were similar (76% f